Divis Laboratories Share Price
₹6370.00
as on
Divis Laboratories Stock Performance
as on January 5, 2026 at 3:02 pm IST
Day's Low
Day's High
₹6,354₹6,447
0.25%
Downside
1.21%
Upside
52 Week's Low
52 Week's High
₹4,955₹7,071.522.21%
Downside
11.01%
Upside
Divis Laboratories share price movements today
- Previous Close
- ₹6,392.50
- Open
- ₹6,370.50
- Volume
- 1.13L
- Upper Circuit
- ₹7,031.50
- Lower Circuit
- ₹5,753.50
- Day's Low - High
- ₹6,354 - ₹6,447
- 52 Week Low - High
- ₹4,955 - ₹7,071.5
Divis Laboratories Historical Returns
- 1 Month Return
- -1.25 %
- 3 Month Return
- + 9.71 %
- 1 Year Return
- + 8.5 %
- 3 Year Return
- + 84.66 %
- 5 Year Return
- + 66.38 %
Divis Laboratories Fundamentals
as on January 5, 2026 at 3:02 pm IST
Market Cap
₹1,69,700.79 Cr
Return on Equity (ROE)
15.57
PE Ratio (TTM)
68.3
Return on capital employed (ROCE)
20.63
Industry PE ratio
41.74
Beta (LTM)
0.87
P/B Ratio
10.27
Dividend Yield
0.52
PEG Ratio
2.79
Quarterly Earnings Growth YOY
35.1
EPS (TTM)
82.68
Sector
Pharmaceuticals
Book Value
564.87
Technical Analysis
Bearish
View Technical Analysis
Divis Laboratories Stock Valuation
as on January 5, 2026 at 3:02 pm IST
Divis Laboratories in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (41.74x)
January 2, 2026
Today (68.30x)
January 2, 2026
Highest (90.48x)
December 4, 2024
Today’s Price to Earnings Ratio: 68.30x
Divis Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Divis Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 1,69,700.79 | 13.28% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,31,496.21 | 35.32% | 0.66 | 1,911 | 11,516 | |
| BUY | 52,535.99 | -3.19% | 0.78 | 1,429 | 15,261 | |
| HOLD | 28,268.91 | -6.1% | 0.53 | 698 | 5,616 | |
| BUY | 1,22,102.70 | 16.55% | 0.51 | 5,291 | 27,547 |
Analyst Recommendation on Divis Laboratories Stock
Based on 31 analysts
43.33%
Buy
16.67%
Hold
40.00%
Sell
Based on 31 analysts, 43.33% of analysts recommend a 'HOLD' rating for Divis Laboratories. Average target price of ₹6785.1
Source: S&P Global Market Intelligence
Divis Laboratories Share Price Target
Get share price movements and forecasts by analysts on Divis Laboratories.
What analysts predicted
6.14%UPSIDE
Target Price
₹6785.1
Current Price
₹6370
Analyzed by
31 Analysts
High
₹9140
Target
₹6785.10
Low
₹4930
Divis Laboratories target price ₹6785.1, a slight upside of 6.14% compared to current price of ₹6370. According to 31 analysts rating.
Source: S&P Global Market Intelligence
Divis Laboratories Stock’s Investor Sentiment and Interest
Investment in Divis Laboratories Ltd Shares on INDmoney has grown by 35.05% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:35.05% versus previous 30 day period
Search interest for Divis Laboratories Ltd Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Divis Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Divis Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Divis Laboratories Ltd Cash Flow
Figures in Rupees Crores
Divis Laboratories Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Divis Laboratories Stock
Check out the Mutual Funds with significant holdings in Divis Laboratories.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 SBI Equity Hybrid Fund Direct Growth | 2.89% | 3700000 | |
SBI Large Cap Fund Direct Growth | 3.18% | 2731710 | |
SBI Focused Fund Direct Plan Growth | 2.68% | 1770000 | |
 Axis ELSS Tax Saver Fund Direct Plan Growth Option | 2.11% | 1143834 | |
Axis Focused Fund Direct Plan Growth Option | 5.12% | 983954 |
Divis Laboratories Corporate Actions
View detailed summary of the earnings and dividend history of Divis Laboratories.
Divis Laboratories Ltd Earnings Results
Divis Laboratories Ltd’s net profit jumped 35.1% since last year same period to ₹689.00Cr in the Q2 2025-2026. On a quarterly growth basis, Divis Laboratories Ltd has generated 26.42% jump in its net profits since last 3-months.
Read More about Earnings ResultsDivis Laboratories Ltd Dividends May,2025
In the quarter ending March 2025, Divis Laboratories Ltd has declared dividend of ₹30.00 per share on 17 May 2025 - translating a dividend yield of 0.94%.
Read More about Dividends
Indices Featuring Divis Laboratories Stock
Check stock indices that include Divis Laboratories.
Insights on Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, DIVISLAB stock has moved up by 9.7%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.52K Cr → 2.86K Cr (in ₹), with an average increase of 11.6% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 13.31% to 13.99% in Sep 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 545.0 Cr → 689.0 Cr (in ₹), with an average increase of 20.9% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 15.5% return, outperforming this stock by 7.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.89% of holdings in Sep 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.9% return, outperforming this stock by 64.2%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 9.32% to 8.96% in Sep 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 19.74% to 19.39% in Sep 2025 quarter
Divis Laboratories Stock Futures & Options Contracts
View the latest movement in Divis Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.
Divis Laboratories Options
Divis Laboratories Futures
About Divis Laboratories Ltd
Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.
Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.
Revenue: ₹2,715.00Cr as on September 2025 (Q2 FY26)
Net Profit: ₹689.00Cr as on September 2025 (Q2 FY26)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
| Organisation | Divis Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | Ramesh B V Nimmagadda |
| E-voting on shares | Click here to vote |
FAQs
What is Divis Laboratories share price today?
Divis Laboratories share price today stands at ₹6370 as on . Divis Laboratories share today touched a day high of ₹6447 and a low of ₹6354.
What is the 52 week high and 52 week low range for Divis Laboratories share?
Divis Laboratories touched a 52 week high of ₹7071.5 and a 52 week low of ₹4955. Divis Laboratories share price today i.e. is trending at ₹6370, which is -9.92% down from its 52 week high and 28.56% up from its 52 week low.
What is Divis Laboratories's market capitalisation today?
Divis Laboratories market capitalisation is ₹1,69,700.79 Cr as on .
How to buy Divis Laboratories shares?
To buy Divis Laboratories shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for DIVISLAB or Divis Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Divis Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Divis Laboratories trading volume today?
Divis Laboratories trading volume is 1.13L as on . This means that 1.13L shares of Divis Laboratories were bought and sold on the stock market during today's trading session.